Boston Scientific
Boston Scientific was founded on the simple premise that less-invasive medicine could improve patient care. We have remained committed to this promise since our founding three decades ago. Today we are a leading innovator of medical devices and technologies that improve patient lives.
Booth No. D003
Exhibition Item
SYNERGY
Learning Center
Satellite Symposium
| Lunchtime Activities |
| State-of-the-art Technologies for SFA Treatment: DES and Atherectomy |
| Organized by CVRF and Supported by Educational Grant from Boston Scientific |
Tuesday, April 25
12:45 PM - 1:45 PM
Endovascular Theater, Level 1 |
| Moderator(s): Donghoon Choi |
| Panelist(s): Seung Hyuk Choi, Jung-Kyu Han, Yoon Seok Koh, Bong-Ki Lee, Han Cheol Lee, Pil Ki Min, Woo Jung Park, Young Jin Youn, Cheol Woong Yu |
|
| 12:45 PM |
Opening Remarks |
| 12:50 PM |
Clinical Results and Ongoing Studies of New Drug Eluting Stent for SFA |
| 1:10 PM |
Clinical Application and Use of Rotational Atherectomy System |
| 1:30 PM |
Panel Discussion
|
| 1:40 PM |
Closing Remarks |
| Lunchtime Activities |
| Leading Innovation and Technology: SYNERGY and POLARIS with FFR |
| Organized by CVRF and Supported by Educational Grant from Boston Scientific |
Wednesday, April 26
12:45 PM - 1:45 PM
Valve Theater, Level 1 |
| Moderator(s): Wook Sung Chung, Hun Sik Park |
| Panelist(s): Yoon Haeng Cho, Byoung-Joo Choi, Seungho Kang, Tae Soo Kang, Bong Ryeol Lee, Jun-Hee Lee, Seung Uk Lee, Chul Soo Park, Wook Bum Pyun, Tae-Hyun Yang |
|
| 12:45 PM |
Opening Remarks |
| 12:50 PM |
EVOLVE First in Man, IVUS Findings for EVOLVE Subsequent Study, and Finally EVOLVE II Data |
| 1:05 PM |
Stent Thrombosis Risk of Drug-Eluting Stents (Data from a Network Meta-Analysis) |
| 1:20 PM |
Introduction to Hybrid Algorithm and Case Presentation |
| 1:35 PM |
Discussion
|
| 1:40 PM |
Closing Remarks |
